Advanced imaging features are offered by Sonosite for cardiac imaging. These include SonoHD imaging technology and SonoMB multibeam imaging technologies, which provide superior contrast resolution and tissue differentiation, supporting complete diagnostic examinations and ultrasound-guided imaging procedures. The systems also offer customized presets for individual clinical applications.
March 8, 2010 – Cardiovascular death is the most common cause of mortality among type 2 diabetics and claims the lives of millions each year, with many diabetics experiencing their first “symptom” as a heart attack or sudden death. Understanding that diabetics are at high risk for coronary heart disease (CHD) and many are asymptomatic, Toshiba America Medical Systems Inc.
March 9, 2010 – During the American College of Cardiology (ACC) 59th Annual Scientific Session, March 14-16, CardiacAssist will host its “Clinical Innovations in TandemHeart Support Symposium and User Group Meeting” from 6-8 p.m. Sunday, March 14, at the W Hotel Midtown, Altitude Room, 188 14th St. NE, in Atlanta.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 9, 2010 — An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac procedure such as a coronary stent implantation found that only three of the tests were associated with a modest ability to predict outcomes such as heart attack or death, according to a study in the Feb.
March 9, 2010 — Initial clinical study results published in the journal Circulation indicates use of a physician-directed, patient self-management system guided by left atrial pressure can improve symptoms and outcomes in patients with heart failure (HF).
March 2, 2010 — Leg arteries that become narrow decrease blood circulation and can cause these extremities to ache or cramp when a person begins exercise. This condition is referred to as intermittent claudication (IC). Although the pain may subside with rest, IC should be taken seriously because it can increase the risk of heart attack and stroke.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 8, 2010 – A self-expanding and disconnectable stent today gained CE mark approval in Europe to treat acute coronary syndrome (ACS).
March 8, 2010 – Advanced visualization and decision support solutions maker TeraRecon was awarded Frost and Sullivan’s “Company of the Year Award,” in the category of medical imaging, advanced visualization applications, Europe 2010. This award represents the fifth time TeraRecon has been recognized with an award from the healthcare market-consulting firm.
March 8, 2010 – Six-month follow-up data on the Stentys drug-eluting and bare metal stents showed a 4 percent restenosis rate in complex lesions.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 8, 2010 – Bifurcation stent developer Tryton Medical Inc. recently announced its Tryton stent implants reached a milestone of 750 patients and recently had its first implants in Portugal and Austria.
March 5, 2010 – Experts will lead an evening symposium during ACC 2010 that will cover the latest clinical and experimental breakthroughs in the percutaneous treatment of coronary artery disease. Those attending will be exposed to the latest clinical trial data on current and second-generation drug-eluting stent therapies.
March 5, 2010 - Vendor neutral archives virtualize enterprise storage and provide on-demand delivery of images and data to locations throughout the enterprise, regardless of where the information is physically stored or where it originated. These capabilities are engineered to streamline IT tasks and help healthcare providers reduce expenses.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
March 5, 2010 - After wavering between an initial offer from Thoma Bravo, LLC for $5.35 per share, and an offer from Merge Healthcare Inc.
March 4, 2010 – During ACC 2010, cardiovascular IT solutions from Siemens will be shown to help optimize clinical workflows through integration of imaging and information, and are designed to make healthcare faster, better and more cost-effective.
March 3, 2010 – Pharmaceutical companies will struggle to profit from the cardiovascular disease (CVD) market over the next decade despite growing drug usage, according to new market research from Datamonitor.